Phase 4 Osteoarthritis Trial, Recruiting (NCT05292339)

Phase 4 Osteoarthritis Trial, Recruiting NCT05292339 Sponsor: Emory University Condition: Osteoarthritis

Printed from Voxsanity (voxsanity.com.au) — NCT05292339 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Osteoarthritis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 18 years old or older
You have painful tendon or joint problems in your shoulder, elbow, hand, or wrist that are causing symptoms
You have not had surgery to treat your condition
Your condition may include trigger finger, De Quervain's tenosynovitis (a painful wrist/thumb condition), or arthritis in certain joints of the wrist or hand (confirm with trial site if unsure which type applies to you)

Who may not be able to join:

You are under 18 years old
You have had an injection of triamcinolone (a steroid) or ketorolac (a pain-relieving medication) in the affected area within the last 6 months
You have previously had surgery to treat your hand or wrist condition
You are allergic to triamcinolone or ketorolac, or have a medical reason why you cannot receive these medications
You currently have an active infection at the area to be treated, such as signs of skin infection, fever, chills, or abnormal infection-related blood test results

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 7 July 2026

Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Principal Investigator: Paul A. Ghareeb, MD, Emory University

Phone: 404-778-3350

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05292339

Sponsor: Emory University

Phase: Phase 4

Status: Recruiting

Condition: Osteoarthritis

Trial contact: 404-778-3350

More information: https://clinicaltrials.gov/study/NCT05292339

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 18 years old or older
You have painful tendon or joint problems in your shoulder, elbow, hand, or wrist that are causing symptoms
You have not had surgery to treat your condition
Your condition may include trigger finger, De Quervain's tenosynovitis (a painful wrist/thumb condition), or arthritis in certain joints of the wrist or hand (confirm with trial site if unsure which type applies to you)

Who may not be able to join:

You are under 18 years old
You have had an injection of triamcinolone (a steroid) or ketorolac (a pain-relieving medication) in the affected area within the last 6 months
You have previously had surgery to treat your hand or wrist condition
You are allergic to triamcinolone or ketorolac, or have a medical reason why you cannot receive these medications
You currently have an active infection at the area to be treated, such as signs of skin infection, fever, chills, or abnormal infection-related blood test results

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 7 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 4

Sponsor

Emory University

Registry

ClinicalTrials.gov

Start date

31 January 2023

Est. completion

1 July 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Changes in Visual Analog Scale (VAS) pain score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov